Cura Therapeutics Inc.

Cura Therapeutics Inc.

Biotechnology Research

Developing First-in-class Immunotherapies to Treat Cancer & Infectious Diseases

About us

Cura Therapeutics is a biotech company developing a first-in-class multifunctional immunotherapy platform to treat a wide range of solid malignancies and infectious diseases. Cura's immunotherapies harness cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties.

Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held
Founded
2020
Specialties
Immunotherapy, Immuno-oncology, drug discovery, virology, immunology, fusion protein, cytokines, oncology, and cancer research

Updates

Similar pages